NCT07277959

Brief Summary

To evaluate the efficacy of the Grommet tube by measuring the rate of reduction in cyst size, assess patients satisfaction, and evaluate the occurrence of complications.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jan 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 2, 2025

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 10, 2025

Completed
10 days until next milestone

Study Completion

Last participant's last visit for all outcomes

October 20, 2025

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

November 28, 2025

Completed
13 days until next milestone

First Posted

Study publicly available on registry

December 11, 2025

Completed
Last Updated

December 11, 2025

Status Verified

January 1, 2025

Enrollment Period

9 months

First QC Date

November 28, 2025

Last Update Submit

December 10, 2025

Conditions

Outcome Measures

Primary Outcomes (3)

  • Reduction in Cyst Size

    Cyst volume will be measured using CBCT and 3D Slicer segmentation at baseline and 6 months after marsupialization. Percentage reduction in cyst size will be calculated.

    6 months

  • Patient Satisfaction

    Patient satisfaction will be assessed using a validated questionnaire (e.g., 3-point Likert scale) at 6 months.

    Time Frame: 6 months

  • Occurrence of Complications

    The presence of postoperative complications (infection, device displacement, or soft tissue overgrowth) will be recorded clinically at follow-up visits.

    Time Frame: 6 months

Interventions

The intervention consisted of performing conventional marsupialization of the odontogenic cyst followed by the novel placement of a ventilation Grommet tube to maintain long-term patency of the surgical window. After administration of local anesthesia, a small bony window was created over the thinnest cortical area of the cyst to expose the cystic cavity. The cyst lining was incised then the tube was placed

Eligibility Criteria

Age15 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

The group of patients in this study consisted of individuals diagnosed with odontogenic cysts who are indicated for marsupialization procedure. Ten patients were enrolled in this study.

You may qualify if:

  • Pathological diagnosis of odontogenic cyst
  • Indicated for marsupialization
  • Patients aged from 15 to 60 years

You may not qualify if:

  • Soft tissue cysts.
  • Patients with systemic diseases affecting bone healing.
  • Patients non-compliance with follow up visits.
  • Patients with a history of neck and head radiotherapy or patients on chemotherapy.
  • Patients taking antiresorptive drugs or corticosteroids.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Anbar-college of dentistry

Ramadi, Iraq

Location

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Postgraduate Student, Department of Oral Surgery

Study Record Dates

First Submitted

November 28, 2025

First Posted

December 11, 2025

Study Start

January 2, 2025

Primary Completion

October 10, 2025

Study Completion

October 20, 2025

Last Updated

December 11, 2025

Record last verified: 2025-01

Locations